| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/07/2001 | WO2001039786A2 New uses of suppressive macrophage activation factors |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001039763A2 Use of methylol-containing compounds for the manufacture of a medicament for the treatment of tumors |
| 06/07/2001 | WO2001039762A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system |
| 06/07/2001 | WO2001039724A2 Phosphonate compounds |
| 06/07/2001 | WO2001039720A2 Dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 06/07/2001 | WO2001032865A8 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 06/07/2001 | WO2001028557B1 Cannabimimetic indole derivatives |
| 06/07/2001 | WO2001025213A3 Pyrrolo imidazole derivatives and their use as medicaments |
| 06/07/2001 | WO2001018028A8 Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds for inhibiting oestrone sulfatase |
| 06/07/2001 | WO2001010902A3 Nucleoc acids and secreted polypeptides encoded thereby |
| 06/07/2001 | WO2001009311A3 Methods of inhibiting cancer cells with adnf iii antisense oligonucleotides |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2000032752A9 Psca: prostate stem cell antigen and uses thereof |
| 06/07/2001 | WO1999063071A3 Method for triggering apoptosis in cells |
| 06/07/2001 | DE19957916A1 Neue Proteinkonjugate und Verfahren zu deren Herstellung New protein conjugates and methods for their preparation |
| 06/07/2001 | DE19955576A1 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 06/07/2001 | CA2747954A1 Phosphonate compounds |
| 06/07/2001 | CA2696185A1 Use of taurolidine and derivatives thereof in the treatment of cancer by induction of apoptosis |
| 06/07/2001 | CA2406316A1 Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
| 06/07/2001 | CA2395094A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents |
| 06/07/2001 | CA2394996A1 Transcription factors containing two potential dna binding motifs |
| 06/07/2001 | CA2393440A1 Curcumin analogs with anti-tumor and anti-angiogenic properties |
| 06/07/2001 | CA2393252A1 Use of methylol-containing compounds to treat tumors |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2393115A1 Methods for cell screening of compounds capable of modulating the activity of ubiquitin-ligase scf complexes and their uses |
| 06/07/2001 | CA2393056A1 New dna polymerase inhibitors, mikanolide and dihydromikanolide |
| 06/07/2001 | CA2393041A1 Method for obtaining nucleic acids from an environment sample, resulting nucleic acids and use in synthesis of novel compounds |
| 06/07/2001 | CA2393026A1 Bryostatin analogues, synthetic methods and uses |
| 06/07/2001 | CA2392991A1 Semaphorin receptor |
| 06/07/2001 | CA2392989A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
| 06/07/2001 | CA2392948A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392693A1 Four disulfide core domain-containing (fdcd) polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2392507A1 Arylamine derivatives and their use as anti-telomerase agent |
| 06/07/2001 | CA2390839A1 Transforming growth factor alpha hiii |
| 06/07/2001 | CA2390415A1 New uses of suppressive macrophage activation factors |
| 06/07/2001 | CA2387108A1 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 06/06/2001 | EP1104809A1 Process for producing alpha-interferon |
| 06/06/2001 | EP1104767A1 Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups |
| 06/06/2001 | EP1104762A1 Substituted imidazo 1,2a]azines as selective inhibotors of cox-2 |
| 06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104677A2 Proteinconjugates and their preparation |
| 06/06/2001 | EP1104486A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 06/06/2001 | EP1104475A1 C-myc is activated by beta-catenin and tcf-4 |
| 06/06/2001 | EP1104465A1 14400 receptor, a g-protein coupled receptor |
| 06/06/2001 | EP1104462A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 06/06/2001 | EP1104461A1 Grip, human adapter protein related to the grb2 family member |
| 06/06/2001 | EP1104456A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 06/06/2001 | EP1104446A1 Biologically active fraction of vegetable melanin, process for its production and its use |
| 06/06/2001 | EP1104440A1 A g-protein coupled 7tm receptor (axor-1) |
| 06/06/2001 | EP1104432A1 Vanadium compounds for treating cancer |
| 06/06/2001 | EP1104423A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 06/06/2001 | EP1104422A1 Phenyl xanthine derivatives |
| 06/06/2001 | EP1104412A1 Tace inhibitors |
| 06/06/2001 | EP1104411A1 Calcilytic compounds |
| 06/06/2001 | EP1104410A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 06/06/2001 | EP1104403A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 06/06/2001 | EP1104309A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/06/2001 | EP1104305A2 Cancer treatment |
| 06/06/2001 | EP1104304A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 06/06/2001 | EP1104297A1 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 06/06/2001 | EP1104293A1 Regulation of substrate activity |
| 06/06/2001 | EP0802914B1 Aryl- and heteroaryl- purine and pyridopyrimidine derivatives |
| 06/06/2001 | EP0695752B1 anthraquinonic derivatives having an antitumor activity, and applications thereof |
| 06/06/2001 | EP0681584B1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 06/06/2001 | EP0536299B1 Surface complexed lymphotoxin |
| 06/06/2001 | CN1298451A Adenoviral vectors for treating disease |
| 06/06/2001 | CN1298445A Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 06/06/2001 | CN1298444A Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 06/06/2001 | CN1298404A Inhibitors of phospholipase A2 |
| 06/06/2001 | CN1298398A 12,13-modified epothilone derivatives |
| 06/06/2001 | CN1298396A N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate |
| 06/06/2001 | CN1298310A Stable mitoxantron solutions |
| 06/06/2001 | CN1298020A CD3-resisting single clone antibody heavy-chain and light-chain variable-area gene and its application |
| 06/06/2001 | CN1298008A Human protein kinase 9 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297935A Human zinc-finger protein 48 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297919A Human zinc-finger protein 69 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297915A Human zinc-finger protein 46 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297914A Human zinc-finger protein 58 as one new kind of polypeptide and polynucleotides encoding this polypeptide |
| 06/06/2001 | CN1297905A Human ribosomal protein L14.22 as one new kind of polypeptide and polynuceotides encoding this polypeptide |
| 06/06/2001 | CN1297766A Compound medicine for leukemia |
| 06/06/2001 | CN1297752A Tumor treating bolus and its preparation |
| 06/06/2001 | CN1297739A Technological process of extracting antineoplastic active component from shark cartilage |
| 06/06/2001 | CN1066734C Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242637 Substituted heterocylic compounds, method of preparing them and pharmaceutical compositions in which they are present |
| 06/05/2001 | US6242616 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives |
| 06/05/2001 | US6242614 10-deacetylbaccatin-iii which is protected at the 7-position with a dialkylalkoxysilyl protecting group; antitumor agents |
| 06/05/2001 | US6242601 Heterocyclic sulfamides |
| 06/05/2001 | US6242590 Antisense modulation of zinc finger protein-217 expression |
| 06/05/2001 | US6242578 Glycoconjugate of carbohydrate covalently bound to peptide of defined amino acid sequence; prevention of influenza virus binding to cells, treatment of schizophrenia, and diagnosis of chronic viral diseases related to cancer |
| 06/05/2001 | US6242575 Antibodies for detecting p27 protein |
| 06/05/2001 | US6242568 Zinc finger protein derivatives and methods therefor |
| 06/05/2001 | US6242481 Administering cytochalasin derivative as anticarcinogenic or antitumor agent |
| 06/05/2001 | US6242479 Use of γ-tocopherol and its oxidative metabolite LLU-α in the treatment of disease |
| 06/05/2001 | US6242477 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds |